Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections – medRxiv

Post author By EvidenceNotFear
Post date 25 August 2021

This study demonstrated that natural immunity confers longer lasting and stronger protection against infection, symptomatic disease and hospitalization caused by the Delta variant of SARS-CoV-2, compared to the BNT162b2 two-dose vaccine-induced immunity. Individuals who were both previously infected with SARS-CoV-2 and given a single dose of the vaccine gained additional protection against the Delta variant.

https://www.medrxiv.org/content/10.1101/2021.08.24.21262415v1

Tags BioNTech, BNT162b2, COVID-19, Delta Variant, Immunity, medRxiv, mRNA, Natural Immunity, Pfizer, Reinfection, Risk, SARS-CoV-2, Vaccination, Variants

Info This site is a curated archive of articles with a link to the source. Keywords and topics covered in the publication can be found above. Click on the tag to view a listing of similar articles.
Links Are any links broken? The page may have been taken down. Visit archive.is or archive.org to view the archive snapshot.
Links Help fight censorship and preserve information on the internet. Archive this source and links on archive.is and archive.org. Save a local copy on your own hard drive.